Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellowship, Medical Oncology, Dana-Farber Cancer Institute 1992 - 1995
  • Residency, Internal Medicine, Brigham and Women's Hospital 1990 - 1992
  • M.D., Duke University School of Medicine 1989
• Recognition
• 

  In the News

  • MAY 17, 2023

    School of Medicine Magnify

    More Options for People With Blood Cancer
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Hourigan, Christopher S., Laura W. Dillon, Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li, et al. “Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease.” J Clin Oncol 38, no. 12 (April 20, 2020): 1273–83. https://doi.org/10.1200/JCO.19.03011.
       Full Text  Link to Item
    • Soiffer, Robert J., Haesook T. Kim, Joseph McGuirk, Mitchell E. Horwitz, Laura Johnston, Mrinal M. Patnaik, Witold Rybka, et al. “Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.” J Clin Oncol 35, no. 36 (December 20, 2017): 4003–11. https://doi.org/10.1200/JCO.2017.75.8177.
       Full Text  Link to Item
    • Liu, Hien Duong, Kwang Woo Ahn, Zhen-Huan Hu, Mehdi Hamadani, Taiga Nishihori, Baldeep Wirk, Amer Beitinjaneh, et al. “Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.” Biol Blood Marrow Transplant 23, no. 5 (May 2017): 767–75. https://doi.org/10.1016/j.bbmt.2017.01.078.
       Full Text  Link to Item
    • Scott, Bart L., Marcelo C. Pasquini, Brent R. Logan, Juan Wu, Steven M. Devine, David L. Porter, Richard T. Maziarz, et al. “Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.” J Clin Oncol 35, no. 11 (April 10, 2017): 1154–61. https://doi.org/10.1200/JCO.2016.70.7091.
       Full Text  Link to Item
    • Shaffer, Brian C., Kwang Woo Ahn, Zhen-Huan Hu, Taiga Nishihori, Adriana K. Malone, David Valcárcel, Michael R. Grunwald, et al. “Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.” J Clin Oncol 34, no. 16 (June 1, 2016): 1864–71. https://doi.org/10.1200/JCO.2015.65.0515.
       Full Text  Link to Item
    • Devine, Steven M., Kouros Owzar, William Blum, Flora Mulkey, Richard M. Stone, Jack W. Hsu, Richard E. Champlin, et al. “Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.” J Clin Oncol 33, no. 35 (December 10, 2015): 4167–75. https://doi.org/10.1200/JCO.2015.62.7273.
       Full Text  Link to Item
    • Jacobson, Caron A., Lixian Sun, Haesook T. Kim, Sean M. McDonough, Carol G. Reynolds, Michael Schowalter, John Koreth, et al. “Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.” Biol Blood Marrow Transplant 20, no. 5 (May 2014): 668–75. https://doi.org/10.1016/j.bbmt.2014.01.021.
       Full Text  Link to Item
    • Cutler, Corey, Haesook T. Kim, Bhavjot Bindra, Stefanie Sarantopoulos, Vincent T. Ho, Yi-Bin Chen, Jacalyn Rosenblatt, et al. “Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.” Blood 122, no. 8 (August 22, 2013): 1510–17. https://doi.org/10.1182/blood-2013-04-495895.
       Full Text  Link to Item
    • Porcheray, Fabrice, David B. Miklos, Blair H. Floyd, Stefanie Sarantopoulos, Roberto Bellucci, Robert J. Soiffer, Joseph H. Antin, Edwin P. Alyea, Jerome Ritz, and Emmanuel Zorn. “Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.” Transplantation 92, no. 3 (August 15, 2011): 359–65. https://doi.org/10.1097/TP.0b013e3182244cc3.
       Full Text  Link to Item
    • Sarantopoulos, Stefanie, Kristen E. Stevenson, Haesook T. Kim, Whitney S. Washel, Nazmim S. Bhuiya, Corey S. Cutler, Edwin P. Alyea, et al. “Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.” Blood 117, no. 7 (February 17, 2011): 2275–83. https://doi.org/10.1182/blood-2010-10-307819.
       Full Text  Link to Item
    • Ho, Vincent T., Matthew Vanneman, Haesook Kim, Tetsuro Sasada, Yoon Joong Kang, Mildred Pasek, Corey Cutler, et al. “Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation.” Proc Natl Acad Sci U S A 106, no. 37 (September 15, 2009): 15825–30. https://doi.org/10.1073/pnas.0908358106.
       Full Text  Link to Item
    • Sarantopoulos, Stefanie, Kristen E. Stevenson, Haesook T. Kim, Corey S. Cutler, Nazmim S. Bhuiya, Michael Schowalter, Vincent T. Ho, et al. “Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.” Blood 113, no. 16 (April 16, 2009): 3865–74. https://doi.org/10.1182/blood-2008-09-177840.
       Full Text  Link to Item
    • Salgia, R., E. Quackenbush, J. Lin, N. Souchkova, M. Sattler, D. S. Ewaniuk, K. M. Klucher, et al. “The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha.” Blood 94, no. 12 (December 15, 1999): 4233–46.
       Link to Item

  • Conference Papers

    • Devine, Steven M., Kouros Owzar, William Blum, Daniel DeAngelo, Richard M. Stone, Jack W. Hsu, Richard E. Champlin, et al. “A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From CALGB 100103/BMT CTN 0502.” In Blood, Vol. 120. AMER SOC HEMATOLOGY, 2012.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.